We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
No take over.
Directors buys should not be allowed during closed, the FCA don't act
Fats
“That's my gut call on GSK, some nice value creation by the end of 2022,”
You do have a tendency to defer price targets and success to some future point in time.
I guess that makes you an investor
PC et all
Emma Walmsley made a catastrophic error in not tacking the carp Credit Suisse put out, my question is this, did she negate her responsibility , to benefit the share awards.
Take note, when the split happens GSK vaccine company will be a sitting duck for a takeover, which to any of the big world biopharma companies would make a great investment as they will be getting gsk on the cheap although when it happens GSKs sp will obviously go north but will still be a good buy. The blinking directors of GSK will love it.
Well I do both so perhaps where the confusion lies.
That's my gut call on GSK, some nice value creation by the end of 2022,
obvs only a guessestimate. Reserve the right to be wrong ).
You can read down the 13F-HR filing, its in Alphabetical Order
https://sec.report/Document/0000950123-21-001657/
fatprofits
I have been watching markets for long enough that I no longer get stressed by these movements ....we have seen them over and over again ....
GSK seems to just be the latest of the behemoths to be cut down at the knee ...
I have patience with this one.... I don't expect a CEO to know it all...but..I do expect them to use the advisors and analysts etc that they have access to and can afford...to which they should be able to make the right decisions
Let us hope the end result comes right
Dodge COX Income fund is the major holder. The fund as 4% holding in GSK for Income/Dividends
Prior to the 30 December holding Dodge COX Holdings in GlaxoSmithKline on September 30th 2020 under SEC Filings was 41,528,300.
Of course the above makes a complet mockery of Credit Suisee take down of GSK .Dodge Cox look for GSK to provide the dividend for minimum period of 15 months, hence the increase , due to the dividend remaining in place for Financial year 2021.
I suppose Dodge Cox have been hoodwinked and the dividend as no value ( cough Cough)
Fats
“where he says...I start every trading day with the mindset that every position“
And then you allude to holding for two years...
I think a lot of people on these boards fail to distinguish between traders and investors
The chasm is huge.
In my book you’re either one or the other
Livermore was a trader
Buffett is an investor
One is short term
The other long term
Which one are you?
Or are you both?
In truth most people on these boards are traders in the definition that they’re looking for a short term gain. (A quick buy and sell at a profit)
It makes me laugh when they quote Buffett’s cliches - unaware that his dogma isn’t relevant to short term traders. They buy what they think will be a short term winner and end up with a long term loser. Then start talking about how it’ll come good in the long term and how they’re in it for the long term. A losing position becomes a badge of honor. Which they wear with pride and vent their wrath on detractors.
Humans are a lot closer to apes than they care to admit.
If they don’t know their own minds how are they going to understand anything that exists outside it?
Poker, as you are probably aware there is a quote from Paul Tudor Jones
where he says...I start every trading day with the mindset that every position
I hold could be wrong - in other words he continually reassesses positions.
However, on GSK, my own gut call would also be a buy and hold for 2 years (post split)
May pay off nicely - gut call Only would stress.
And sadly I'm not a multi billionaire and PTJ is.
So a significant move up to 154,086,234 ADR's from 62,935,758 alone in under 2 months.
SEC filings for quarter ending 30/12/2020 under 13 F HR Filing showed Dodge Cox held 62,935,758 GSK shares under ADR
I am leaving my holding for 6 months and will then re-look...treating it like a fund
What traders do , on a day to day business..is out of my control
but...they play around whilst they think no news is due...then the games play stops and they get more serious, once again ..
It is the way the financial mafia operates
We need a £5 jump in price immediately to pacify the hungry mob.
i think they increased their holding to over 5% from below 3%. its interesting that it has happened with the cable rate being where it is, after a very big rally over the last 12 months. i dont know the tax system in the usa but its possible they booked a profit on something else and had the sterling from lower levels. you never know. but its certainly better for sentiment that they bought in here at what are optically high sterling levels.
FP,
They ( https://www.dodgeandcox.com/ ) may of well held ... no way to confirm that .... if they indeed were already holders, Dodge added at the very least 2.04% (from an assumed starting point of 2.99%) recently .... not an insignificant sum ... of course it may be a lot higher as I doubt their starting point was 2.99% .... more than happy to see a TR-1, esp one that has a holding amounting to 5.04%.
atb
There is comment elsewhere that Dodge have held GSK for the last 10 years,
it's not something I'm aware of tbh.
The FCA, lazy shower of overpaid and underworked B......s, should instigate a full inquiry into how the London Stock Exchange is unscrupulously run by a criminal element, deserving hefty prison sentences.
We want to see them bleed.
Sorry for the bad language , as it is not my usual form.
Yep, this RNS would not have gone un-noticed by the Algos .... shorts are already in the process of controlled closure atm .... with other funds loading up too .... so few days around this SP, before steady climb beginning next week imo.
Only a month away from new ISA's allowance too.
"...the Fund typically invests in companies that, in Dodge & Cox's opinion, appear to be temporarily undervalued by the stock market..."
The above is a very short extract on their Global fund information.
Much more info on their website for anyone particularly interested!.
TR1
https://www.londonstockexchange.com/news-article/GSK/holding-s-in-company/14877298
253,464,108 SHARES BOUGHT They know good news in bound GLA